"epithelial ovarian cancer" trang 3 - tải miễn phí từ tailieuXANH
Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration
11    107    0
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
10    78    0
“Chronic fatigue, quality of life and longterm side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: National case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors”

“Chronic fatigue, quality of life and longterm side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: National case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors”
12    38    1
Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens

Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens
15    59    0
Evaluation of characteristics of CD44+ CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures

Evaluation of characteristics of CD44+ CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures
11    29    1
Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion

Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion
9    100    0
The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells

The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells
12    54    0
Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma
9    71    0
Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer

Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer
14    44    1
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
13    47    0
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer

Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
12    53    0
Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
5    60    0
Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential
13    67    0
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis
11    117    0
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
8    49    0
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: A competing risk analysis

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: A competing risk analysis
8    78    0
Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer

Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
11    51    0
Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
9    64    0
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
7    57    0
Role of malignant ascites on human mesothelial cells and their gene expression profiles

Role of malignant ascites on human mesothelial cells and their gene expression profiles
13    66    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.